BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25746632)

  • 1. Treatment options for community-acquired pneumonia in the elderly people.
    Petrosillo N; Cataldo MA; Pea F
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):473-85. PubMed ID: 25746632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for community-acquired pneumonia in the elderly.
    Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J
    Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy of community-acquired pneumonia.
    File TM; Niederman MS
    Infect Dis Clin North Am; 2004 Dec; 18(4):993-1016, xi. PubMed ID: 15555836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines.
    Carbonara S; Stano F; Scotto G; Monno L; Angarano G
    New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the management of community-acquired pneumonia in the elderly patient.
    González-Castillo J; Martín-Sánchez FJ; Llinares P; Menéndez R; Mujal A; Navas E; Barberán J; ; ; ; ;
    Rev Esp Quimioter; 2014 Mar; 27(1):69-86. PubMed ID: 24676248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of community-acquired pneumonia in adults.
    Working Group of the South African Thoracic Society
    S Afr Med J; 2002 Aug; 92(8 Pt 2):647-55. PubMed ID: 12244941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
    Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
    Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults.
    Hashemi SH; Soozanchi G; Jamal-Omidi S; Yousefi-Mashouf R; Mamani M; Seif-Rabiei MA
    Trop Doct; 2010 Apr; 40(2):89-91. PubMed ID: 20305102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia in the elderly.
    Torres A; El-Ebiary M; Riquelme R; Ruiz M; Celis R
    Semin Respir Infect; 1999 Jun; 14(2):173-83. PubMed ID: 10391411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolones in the management of community-acquired pneumonia.
    Albertson TE; Dean NC; El Solh AA; Gotfried MH; Kaplan C; Niederman MS
    Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.
    Falagas ME; Metaxas EI
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):913-23. PubMed ID: 19803699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia in the elderly.
    Fung HB; Monteagudo-Chu MO
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):47-62. PubMed ID: 20226392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-acquired pneumonia.
    Brown PD; Lerner SA
    Lancet; 1998 Oct; 352(9136):1295-302. PubMed ID: 9788476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New guidelines for the management of adult community-acquired pneumonia.
    Armitage K; Woodhead M
    Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.